

* Returns not adjusted for payouts
Company Profile
The Company was incorporated in Pakistan as a private limited Company on November 12, 2004 under the Companies Ordinance, 1984 (now the Companies Act, 2017) and was converted into a public limited company with effect from February 28, 2008 as approved by the Securities and Exchange Commission of Pakistan (SECP). The Company is principally engaged in manufacture, procurement and sale of hydrogen peroxide and allied products. The Company commenced its trial production on December 1, 2008 and commercial production on March 1, 2009.
Mr. Muhammad Mohsin Zia | CEO |
Mr. Faisal Dawood | Chairman |
Mr. Abdul Sohail | Company Secretary |
M/s Corplink (Pvt.) Limited Wings Arcade, 1-K Commercial Area, Model Town, Lahore.
M/s A.F Fergusons & Co, Chartered Accoutants.
June
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Apr 27, 2023 | Transmission of Quarterly Report for the Period Ended 2023-03-31 | View PDF |
Apr 18, 2023 | Financial Results for the Quarter Ended | View PDF |
Feb 28, 2023 | Transmission of Quarterly Report for the Period Ended 31-12-2022 | View PDF |
Feb 14, 2023 | Financial Results For the Period Ended 31-12-2022 | View PDF |
Feb 14, 2023 | Financial Results for the Quarter Ended 2022-12-31 | View PDF |
Dec 14, 2022 | CORPORATE BRIEFING SESSION (CBS) YEAR ENDED JUNE 30 2022 | View PDF |
Dec 9, 2022 | Corporate Briefing Session for the year ended June 30, 2022 REVOKED | View PDF |
Oct 27, 2022 | Transmission of Quarterly Report for the Period Ended 30-09-2022 | View PDF |
Oct 21, 2022 | Financial Results for the Quarter Ended 30-09-2022 | View PDF |
Sep 28, 2022 | Transmission of Annual Report for the Year Ended | View PDF |
Date | Title | Document |
---|---|---|
Jun 9, 2023 | Board Meeting Other Than Financial Results | View PDF |
Jun 5, 2023 | Notice of Extraordinary General Meeting | View PDF |
Jun 1, 2023 | BOARD OF DIRECTORS MEETING OTHER THAN FINANCIAL RESULTS | View PDF |
May 30, 2023 | Board Meeting Other Than Financial Results | View PDF |
Apr 10, 2023 | BOARD MEETING | View PDF |
Feb 14, 2023 | Notice of Extraordinary General Meeting | View PDF |
Feb 13, 2023 | Board Meeting In Progress | View PDF |
Feb 6, 2023 | Board Meeting | View PDF |
Feb 6, 2023 | Notice of Extraordinary General Meeting | View PDF |
Oct 31, 2022 | Resolutions Passed at the 18th Annual General Meeting of Descon Oxychem Ltd | View PDF |
Oct 20, 2022 | Board meeting in progress | View PDF |
Oct 12, 2022 | board of directors meeting descon oxychem limited | View PDF |
Sep 28, 2022 | Notice of Annual General Meeting | View PDF |
Sep 7, 2022 | DOL | Descon Oxychem Limited - Meeting in Progress |
Date | Title | Document |
---|---|---|
May 2, 2023 | Material Information | View PDF |
Mar 27, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Mar 3, 2023 | Credit of Interim Cash Dividend | View PDF |
Feb 28, 2023 | APPOINTMENT OF CHAIRMAN AND CEO OF THE COMPANY | View PDF |
Feb 28, 2023 | ELECTION OF DIRECTORS | View PDF |
Feb 20, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 29, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 29, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 21, 2022 | Material Information | View PDF |
Dec 21, 2022 | Material Information | View PDF |
Financials
All numbers in thousands (000's) except EPS
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Sales | 4,250,493 | 2,804,903 | 2,641,615 | 2,704,957 |
Profit after Taxation | 470,877 | 278,703 | 418,423 | 394,269 |
EPS | 2.69 | 1.59 | 2.58 | 3.87 |
Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | |
---|---|---|---|---|
Sales | 1,699,937 | 1,782,486 | 1,700,225 | 982,107 |
Profit after Taxation | 293,086 | 488,981 | 518,832 | 25,716 |
EPS | 1.67 | 2.79 | 2.96 | 0.15 |

Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Gross Profit Margin (%) | 25.92 | 21.85 | 32.60 | 30.71 |
Net Profit Margin (%) | 11.08 | 9.94 | 15.84 | 14.58 |
EPS Growth (%) | 69.18 | (38.37) | (33.33) | 22.47 |
PEG | 0.08 | (0.44) | (0.35) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
February 14, 2023 3:17 PM | 31/12/2022(HYR) | 20%(i) (D) | 21/02/2023 - 23/02/2023 |
September 8, 2022 3:59 PM | 30/06/2022(YR) | 20%(F) (D) | 12/10/2022 - 20/10/2022 |
September 8, 2021 3:18 PM | 30/06/2021(YR) | 10%(F) (D) | 18/10/2021 - 25/10/2021 |
September 3, 2020 4:12 PM | 30/06/2020(YR) | 10%(F) (D) - 16% (B) | 13/10/2020 - 21/10/2020 |
February 14, 2019 2:22 PM | 31/12/2018(HYR) | 10%(i) (D) | 07/03/2019 - 14/03/2019 |
August 16, 2018 9:38 AM | 30/06/2018(YR) | 12% (P) | 15/10/2018 - 23/10/2018 |
April 23, 2015 5:05 PM | 30/06/2012(YR) | 100% PREFERENCE AT PAR (R) | - |